Takeda Pharmaceutical Co., Ltd. et al v. IMPAX Laboratories, Inc.

Filing 114

ORDER CONTINUING CASE MANAGEMENT CONFERENCE. Signed by Judge Lucy Koh on 10/29/14. (lhklc5S, COURT STAFF) (Filed on 10/29/2014)

1
2
3
4
5
UNITED STATES DISTRICT COURT
6
NORTHERN DISTRICT OF CALIFORNIA
7
SAN JOSE DIVISION
8

10

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS U.S.A.,
INC., AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

11

Plaintiffs,

United States District Court
For the Northern District of California

9

12
13
14

v.
IMPAX LABORATORIES, INC.,
Defendant.

)
)
)
)
)
)
)
)
)
)
)
)
)

Case No.:

13-CV-02416-LHK

ORDER CONTINUING CASE
MANAGEMENT CONFERENCE

15
16

In light of the Court’s order staying all deadlines for 45 days pending regulatory review of

17

the parties’ settlement (ECF No. 113), the case management conference set for November 5, 2014

18

is hereby CONTINUED to December 10, 2014, at 2:00 P.M., should it be necessary following the

19

regulatory review period.

20

IT IS SO ORDERED.

21

Dated: October 29, 2014

_________________________________
LUCY H. KOH
United States District Judge

22
23
24
25
26
27
28
1

Case Nos.: 13-CV-02416-LHK
ORDER CONTINUING CASE MANAGEMENT CONFERENCE